Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
Xin Wang, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan, Xavier Jacq, Niall M.B. Martin, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 57-78
Open Access | Times Cited: 731
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, et al.
Cancer and Metastasis Reviews (2017) Vol. 36, Iss. 4, pp. 561-584
Closed Access | Times Cited: 299
Redox Signaling by Reactive Electrophiles and Oxidants
Saba Parvez, Marcus J. C. Long, Jesse R. Poganik, et al.
Chemical Reviews (2018) Vol. 118, Iss. 18, pp. 8798-8888
Open Access | Times Cited: 297
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Deubiquitinases in cancer
Grant Dewson, Pieter J.A. Eichhorn, David Komander
Nature reviews. Cancer (2023) Vol. 23, Iss. 12, pp. 842-862
Closed Access | Times Cited: 110
USP14-regulated allostery of the human proteasome by time-resolved cryo-EM
Shuwen Zhang, Shitao Zou, Deyao Yin, et al.
Nature (2022) Vol. 605, Iss. 7910, pp. 567-574
Open Access | Times Cited: 78
USP14: Structure, Function, and Target Inhibition
Feng Wang, Shuo Ning, Beiming Yu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 76
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7
Ilaria Lamberto, Xiaoxi Liu, Hyuk‐Soo Seo, et al.
Cell chemical biology (2017) Vol. 24, Iss. 12, pp. 1490-1500.e11
Open Access | Times Cited: 162
Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
Nathan J. Schauer, Robert S. Magin, Xiaoxi Liu, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 6, pp. 2731-2750
Closed Access | Times Cited: 143
From Discovery to Bedside: Targeting the Ubiquitin System
Ingrid E. Wertz, Xiao‐Jing Wang
Cell chemical biology (2018) Vol. 26, Iss. 2, pp. 156-177
Open Access | Times Cited: 133
Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers
Hong‐Beom Park, Ju-Won Kim, Kwang‐Hyun Baek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3904-3904
Open Access | Times Cited: 117
Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Ainsley Mike Antao, Apoorvi Tyagi, Kye-Seong Kim, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1579-1579
Open Access | Times Cited: 113
Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights
David S. Hewings, John A. Flygare, Matthew Bogyo, et al.
FEBS Journal (2017) Vol. 284, Iss. 10, pp. 1555-1576
Open Access | Times Cited: 111
Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders
Evert Njomen, Jetze J. Tepe
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 14, pp. 6469-6481
Open Access | Times Cited: 106
Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
Matthew Ho, Emma Kavanagh, Luke Dunne, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 66-66
Open Access | Times Cited: 105
Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
Xiaonan Zhang, Stig Linder, Martina Bazzaro
Cancers (2020) Vol. 12, Iss. 4, pp. 902-902
Open Access | Times Cited: 105
Proteasome-associated deubiquitinases and cancer
Arjan Mofers, Paola Pellegrini, Stig Linder, et al.
Cancer and Metastasis Reviews (2017) Vol. 36, Iss. 4, pp. 635-653
Open Access | Times Cited: 96
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 88
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky, Agne Paner, Jesús G. Berdeja, et al.
Investigational New Drugs (2020) Vol. 38, Iss. 5, pp. 1448-1453
Open Access | Times Cited: 80
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
Lucas Lopes Cruz, Paula Soares, Marcelo Correia
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 848-848
Open Access | Times Cited: 66
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante, Wei Zhang
Cancers (2021) Vol. 13, Iss. 12, pp. 3079-3079
Open Access | Times Cited: 58
Deubiquitylating Enzymes in Cancer and Immunity
Jiang Ren, Peng Yu, Sijia Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 32
Recent advances in the development of deubiquitinases inhibitors as antitumor agents
Lili Zheng, Liting Wang, Ye-Wei Pang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116161-116161
Closed Access | Times Cited: 13
Privileged Electrophile Sensors: A Resource for Covalent Drug Development
Marcus J. C. Long, Yimon Aye
Cell chemical biology (2017) Vol. 24, Iss. 7, pp. 787-800
Open Access | Times Cited: 79
Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer
Matthew Saldana, Kacey VanderVorst, Anastasia L. Berg, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 1, pp. R1-R14
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top